- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly.
November 10, 2022
Development of a new two-arm transurethral surgical system for en bloc resection of bladder tumor-A preclinical study.
November 10, 2022
First-Line Sequential Gemcitabine and Docetaxel Treatment for High-Risk Non-Muscle Invasive Bladder Cancer - Expert Commentary
November 9, 2022
5α-reductase inhibitors and the risk of bladder cancer in a large, population-based cohort.
November 9, 2022
Molecular Taxonomy and Immune Checkpoint Therapy in Bladder Cancer.
November 9, 2022
Real-World Data to Derive Biomarkers of Response to Therapy in Patients with Metastatic Urothelial Cancer - Expert Commentary
November 8, 2022
CMS Improves Medicare Reimbursement for Blue Light Cystoscopy with Cysview and Expands Access in the Surveillance Setting
November 8, 2022
A DNA Methylation Test for Follow-up of Patients with Non-Muscle Invasive Bladder Cancer - Expert Commentary
November 7, 2022
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.
November 7, 2022
Epidemiology, Screening, and Prevention of Bladder Cancer.
November 7, 2022
Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer.
November 4, 2022
En-bloc transurethral resection vs. conventional transurethral resection for primary non-muscle invasive bladder cancer: A meta-analysis.
November 4, 2022
Mutational Profiles of Urothelial Cancer Samples after Kidney Transplantation - Expert Commentary
November 3, 2022
Correlation between PD-L1 expression of the tumour cells and lymphocytes infiltration in the invasive front of urothelial carcinoma.
November 3, 2022
Multi-Sequence and Multi-Regional MRI-Based Radiomics Nomogram for the Preoperative Assessment of Muscle Invasion in Bladder Cancer.
November 3, 2022
